These results suggest that 10 and 20 mg/kg BW ILA ameliorates diet-induced liver lipid accumulation, dyslipidemia, and liver injury and enhances hepatic bile acid synthesis and excretion by activating CYP7A1 and FXR-BSEP. Here, ABCB11 is linked to metabolic syndrome.